Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04995770 · ClinicalTrials.gov registry record · NA
Text Messages for Liver Transplant Recipients
A NA study of Medication Adherence and Liver Transplant Disorder, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT04995770: Completed NA study of Medication Adherence and Liver Transplant Disorder, sponsored by Children's Hospital Los Angeles.
NCT04995770 is a NA study of Medication Adherence and Liver Transplant Disorder that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 35 participants, below the 1,656-participant average among 52 other Medication Adherence trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04995770, a NA study of Medication Adherence and Liver Transplant Disorder, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Although medical advancements have enabled children experiencing liver transplants to live longer, medical management post-transplant is ongoing and complex. Many findings underscore adolescents as being a particularly vulnerable population, with rates of nonadherence being four times higher than in adults. This pilot study aims to explore the feasibility and impact of a brief text-messaging intervention in a randomized controlled trials (N = 50). We have three primary aims: 1) Study patient satisfaction with and utilization of this intervention in order to better understand feasibility and acceptability; 2) Investigate the effects of this intervention on medication adherence, healthcare utilization, and health status; and 3) Examine potential effects of the intervention on the physician-patient relationship, motivation for adherence, and other variables.
Primary Outcome
Visual Analogue Scale (0-100% range, with higher scores indicating better values)
Conditions Studied
Interventions
- BEHAVIORAL Praise Text Messages
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2020-12-26 |
| Phase | NA |
What the finished NCT04995770 record still lists
NCT04995770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,656-participant average among 52 other Medication Adherence trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Praise Text Messages is the first listed.
NCT04995770 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04995770 about?
NCT04995770 is a clinical study titled "Text Messages for Liver Transplant Recipients". Although medical advancements have enabled children experiencing liver transplants to live longer, medical management post-transplant is ongoing and complex. Many findings underscore adolescents as being a particularly vulnerable population, with rates of nonadherence being four times higher than in...
What is the current status of trial NCT04995770?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-08-01. Estimated completion is 2020-12-26.
What conditions does trial NCT04995770 study?
This clinical trial studies the following conditions: Medication Adherence, Liver Transplant Disorder.
What interventions are being tested in trial NCT04995770?
The interventions under investigation include: Praise Text Messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT04995770?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04995770 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Adherence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04995770's enrollment target sits among peer trials
35 48th of 52 higher than 5 of 52 other Medication Adherence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Medication Adherence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Medication Adherence Program
RECRUITING · NA
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
RECRUITING · NA
-
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
RECRUITING · NA
-
Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI